Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis

• Published in: Brain Sciences
• Main Authors: Dario Ricciardi, Federica Amitrano, Armando Coccia, Vincenzo Todisco, Francesca Trojsi, Gioacchino Tedeschi, Giovanni Cirillo
• Format: Article in Journal/Newspaper
• Language: English
• Published: MDPI AG 2022
• Subjects: chronic inflammatory demyelinating polyneuropathy; EMG; axonal degeneration; motor unit analysis; subcutaneous immunoglobulin; Neurosciences. Biological psychiatry. Neuropsychiatry; RC321-571; DML
• Online Access: https://doi.org/10.3390/brainsci12111510; https://doaj.org/article/84f146db56e84630932dada707e0f377

In this work, we aim to identify sensitive neurophysiological biomarkers of axonal degeneration in CIDP patients. A total of 16 CIDP patients, fulfilling the clinical and neurophysiological criteria for typical CIDP, treated with subcutaneous immunoglobulin (ScIg) (0.4 g/kg/week) were evaluated at baseline (before ScIg treatment) and after long-term treatment with ScIg (24 months) by clinical assessment scales, nerve conduction studies (NCS) and electromyography (EMG). Conventional and non-conventional neurophysiological parameters: motor unit potential (MUP) analysis, MUP thickness and size index (SI)] and interference pattern (IP) features were evaluated after long-term treatment (24 months) and compared with a population of 16 healthy controls (HC). An increase of distal motor latency (DML) and reduced compound motor action potential (CMAP) amplitude and area in CIDP patients suggest axonal damage of motor fibers, together with a significant increase of MUP amplitude, duration and area. Analysis of non-conventional MUP parameters shows no difference for MUP thickness; however, in CIDP patients, SI is increased and IP area and amplitude values are lower than HC. Despite clinical and neurophysiological improvement after ScIg treatment, neurophysiological analysis revealed axonal degeneration of motor fibers and motor unit remodeling. Correlation analysis shows that the axonal degeneration process is related to the diagnostic and therapeutic delay. MUP area and SI parameters can detect early signs of axonal degeneration, and their introduction in clinical practice may help to identify patients with the worst outcome.